João Luis Garcia

João Luis Garcia

Auto-generated profile, based on publicly available information

João Luis Garcia

Department of Preventive Veterinary Medicine, Laboratory of Animal Protozoology, Universidade Estadual de Londrina, Rodovia Celso Garcia Cid, Pr 445 km 380, 86057-970 Londrina, PR, Brazil

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2007 in Research in Veterinary Science
Verified
Journal Article
Closed access
PRP.R. Romanelli
P.R. Romanelli
RFR.L. Freire
R.L. Freire
OVO. Vidotto
O. Vidotto
EME.R.M. Marana
E.R.M. Marana
LOL. Ogawa
L. Ogawa
INI.T. Navarro
I.T. Navarro

1 June 2019 in Food and Waterborne Parasitology
Verified
Journal Article
Open access
EIElisabeth A. Innes
Elisabeth A. Innes
CHClare Hamilton
Clare Hamilton
JGJoao L. Garcia
Joao L. Garcia
ACAndreas Chryssafidis
Andreas Chryssafidis
DSDavid Smith
David Smith
Toxoplasmosis is a serious disease with global impact, now recognised as one of the most important food borne diseases worldwide and a major cause of production loss in livestock. A one health approach to develop a vaccination programme to tackle toxoplasmosis is an attractive and realistic prospect. Knowledge of disease epidemiology, parasite transmission routes and main risk groups has helped to target key host species and outcomes for a vaccine programme and these would be to prevent/reduce congenital disease in women and sheep; prevent/reduce T. gondii tissue cysts in food animal species and to prevent/reduce T. gondii oocyst shedding in cats. Most animals, including humans, develop good protective immunity following infection, involving cell mediated immune responses, which may explain why live vaccines are generally more effective to protect against T. gondii. Recent advances in our knowledge of parasite genetics and gene manipulation, strain variation, key antigenic epitopes, delivery systems and induction of immune responses are all contributing to the prospects of developing new vaccines which may be more widely applicable. A key area in progressing vaccine development is to devise standard vaccine efficacy models in relevant animal hosts and this is where a one health approach bringing together researchers across different disciplines can be of major benefit. The tools and technologies are in place to make a real impact in tackling toxoplasmosis using vaccination and it just requires a collective will to make it happen.

1 January 2018 in Veterinary Parasitology
Verified
Journal Article
Closed access
DZDauton Luiz Zulpo
Dauton Luiz Zulpo
ASAna Sue Sammi
Ana Sue Sammi
JSJoeleni Rosa dos Santos
Joeleni Rosa dos Santos
JSJoão Pedro Sasse
João Pedro Sasse
TMThais Agostinho Martins
Thais Agostinho Martins
JGJoão Luis Garcia
João Luis Garcia

1 August 2006 in Experimental Parasitology
Verified
Journal Article
Closed access
JGJoão Luis Garcia
João Luis Garcia
SGSolange Maria Gennari
Solange Maria Gennari
RMRosângela Zacarias Machado
Rosângela Zacarias Machado
INItalmar Teodorico Navarro
Italmar Teodorico Navarro

4 January 2013 in Journal of Veterinary Diagnostic Investigation
Verified
Journal Article
Open access
Selwyn Arlington HeadleySelwyn Arlington Headley
Selwyn Arlington Headley
AAAmauri Alcindo Alfieri
Amauri Alcindo Alfieri
JFJuliana Torres Tomazi Fritzen
Juliana Torres Tomazi Fritzen
JGJoão Luis Garcia
João Luis Garcia
Herbert WeissenböckHerbert Weissenböck
Herbert Weissenböck
AAAlice Fernandes Alfieri
Alice Fernandes Alfieri
The concomitant infections of Canine distemper virus (CDV), Canine adenovirus A types 1 (CAdV-1) and 2 (CAdV-2), Canine parvovirus type 2 (CPV-2), and Toxoplasma gondii are described in a 43-day-old mixed-breed puppy. Clinically, there were convulsions and blindness with spontaneous death; 14 siblings of this puppy, born to a 10-month-old dam, which was seropositive (titer: 1,024) for T. gondii, also died. Necropsy revealed unilateral corneal edema (blue eye), depletion of intestinal lymphoid tissue, non-collapsible lungs, congestion of meningeal vessels, and a pale area in the myocardium. Histopathology demonstrated necrotizing myocarditis associated with intralesional apicomplexan protozoa; necrotizing and chronic hepatitis associated with rare intranuclear inclusion bodies within hepatocytes; necrotizing bronchitis and bronchiolitis; interstitial pneumonia associated with eosinophilic intracytoplasmic inclusion bodies within epithelial cells; atrophy and fusion of intestinal villi with cryptal necrosis; and white matter demyelination of the cerebrum and cerebellum associated with intranuclear inclusion bodies within astrocytes. Polymerase chain reaction (PCR) amplified the partial fragments (bp) of the CDV N gene (290 bp), CPV-2c VP2 capsid protein gene (583 bp), and CAdV-1 (508 bp) and CAdV-2 (1,030 bp) E gene from urine and tissue samples. The PCR assays demonstrated that the apicomplexan protozoa observed within several organs contained DNA specific for T. gondii; genotyping revealed T. gondii type III. The findings support the characterization of concomitant infections of CDV, CAdV-1, CAdV-2, CPV-2, and T. gondii in this puppy. Further, seroreactivity to T. gondii of the dam in association with the systemic disease observed in the puppy described herein is suggestive of congenital toxoplasmosis.

1 June 2006 in Experimental Parasitology
Verified
Journal Article
Closed access
JGJoão Luis Garcia
João Luis Garcia
INItalmar Teodorico Navarro
Italmar Teodorico Navarro
OVOdilon Vidotto
Odilon Vidotto
SGSolange Maria Gennari
Solange Maria Gennari
RMRosângela Zacarias Machado
Rosângela Zacarias Machado
ISIdercio Luiz Sinhorini
Idercio Luiz Sinhorini